Thomas Eklund

Thomas Eklund is the Chairman at Moberg Pharma and Calliditas. He also serves as Industrial Partner at Impilo and Chairman at Biotage. He was the Chairman of GHP Specialty Care and BoMill. He served as Managing Director at Investor Growth Capital. He joined the Investor Growth Capital Europe team as Managing Director in 2002 and has served as Head of the Stockholm office since 2006. He focuses on expansion-stage investments in device and pharmaceutical companies and has been responsible for investments in Carmel Pharma, Swedish Orphan International and Entific Medical Syste Prior to joining IGC, he spent two years as Investment Director of ABN Amro Capital Investments where he was responsible for investment processing of expansion capital and MBO transactions in the Nordic region. Investments managed during his time at ABN Amro include MBOs of Champion Inc. and Biovitrum AB. In addition, He served a Vice President of the healthcare group at Handelsbanken Securities Corporate Finance. He received an M.B.A. from the Stockholm School of Economics. [Source: Public Company Filing]